ORIGINAL RESEARCH
Accepted on 20 May 2025
Safety and Efficacy of Sintilimab versus Pembrolizumab in the Treatment of Advanced or Recurrent Pediatric Malignancies: A Real-World Study in China
doi 10.3389/fimmu.2025.1608844
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Next-Generation Treatment for Pediatric Cancer: Advancing Immunotherapy through Combinations
Next-Generation Treatment for Pediatric Cancer: Advancing Immunotherapy through Combinations
273
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: